Category:Health Canada approved in 2017

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

Pages in category "Health Canada approved in 2017"

The following 6 pages are in this category, out of 6 total.

A

D

Durvalumab (Imfinzi)

I

Irinotecan liposome (Onivyde)

N

Necitumumab (Portrazza)

O

Olaratumab (Lartruvo)

Retrieved from "https://hemonc.org/w/index.php?title=Category:Health_Canada_approved_in_2017&oldid=67458"

Health Canada approved drugs